Insider Buy/Sell Details for the Healthcare Sector — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (171)
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
1,600
Price
$14.38
Total Value
$23.01K
Shares Held After
11,845,939
% of Holdings
0.0%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
214,839
Price
$14.12
Total Value
$3.03M
Shares Held After
11,844,339
% of Holdings
1.8%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
300,000
Price
$13.90
Total Value
$4.17M
Shares Held After
11,629,500
% of Holdings
2.6%
Bausch & Lomb Corp (BLCO)
VON ESCHENBACH ANDREW C. — Director
Shares
4,364
Price
$18.30
Total Value
$79.88K
Shares Held After
66,450
% of Holdings
6.6%
ZIVO Bioscience, Inc. (ZIVO)
YALDOO LAITH L — Director
Shares
1,543
Price
$9.72
Total Value
$15.00K
Shares Held After
583,615
% of Holdings
0.3%
AdaptHealth Corp. (AHCO)
WOLF DALE B — Director
Shares
8,000
Price
$8.96
Total Value
$71.68K
Shares Held After
104,235
% of Holdings
7.7%
Absci Corp (ABSI)
Pangalos Menelas N — Director
Shares
75,095
Price
$2.74
Total Value
$205.76K
Shares Held After
189,055
% of Holdings
39.7%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
30,000
Price
$2.22
Total Value
$66.70K
Shares Held After
371,702
% of Holdings
8.1%
Claritev Corp (CTEV)
Kim Michael — EVP, Chief Digital Officer
Shares
30,000
Price
$14.30
Total Value
$428.95K
Shares Held After
137,973
% of Holdings
21.7%
Claritev Corp (CTEV)
Dalton Travis — Director
Shares
15,380
Price
$13.00
Total Value
$199.93K
Shares Held After
24,952
% of Holdings
61.6%
Larimar Therapeutics, Inc. (LRMR)
Hamilton Thomas Edward — Director
Shares
100,000
Price
$5.00
Total Value
$500.00K
Shares Held After
664,798
% of Holdings
15.0%
Larimar Therapeutics, Inc. (LRMR)
Flynn James E — Director
Shares
2,000,000
Price
$5.00
Total Value
$10.00M
Shares Held After
6,207,982
% of Holdings
32.2%
Larimar Therapeutics, Inc. (LRMR)
Flynn James E — Director
Shares
831,978
Price
$5.00
Total Value
$4.16M
Shares Held After
8,153,107
% of Holdings
10.2%
Larimar Therapeutics, Inc. (LRMR)
Flynn James E — Director
Shares
1,084,012
Price
$5.00
Total Value
$5.42M
Shares Held After
10,622,957
% of Holdings
10.2%
Larimar Therapeutics, Inc. (LRMR)
Flynn James E — Director
Shares
1,084,010
Price
$5.00
Total Value
$5.42M
Shares Held After
10,622,928
% of Holdings
10.2%
Larimar Therapeutics, Inc. (LRMR)
SHERMAN JEFFREY W — Director
Shares
5,000
Price
$5.00
Total Value
$25.00K
Shares Held After
5,000
% of Holdings
100.0%
Larimar Therapeutics, Inc. (LRMR)
THOMAS FRANK E — Director
Shares
5,000
Price
$5.00
Total Value
$25.00K
Shares Held After
7,000
% of Holdings
71.4%
AbCellera Biologics Inc. (ABCL)
Thermopylae Holdings Ltd. — 10% Owner
Shares
38,000
Price
$3.44
Total Value
$130.72K
Shares Held After
56,134,097
% of Holdings
0.1%
FibroBiologics, Inc. (FBLG)
GARCIA RUBEN A — General Counsel
Shares
40,000
Price
$0.33
Total Value
$13.06K
Shares Held After
180,000
% of Holdings
22.2%
PALVELLA THERAPEUTICS, INC. (PVLA)
HERON ELAINE J — Director
Shares
2,400
Price
$125.00
Total Value
$300.00K
Shares Held After
47,812
% of Holdings
5.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
4,000
Price
$125.00
Total Value
$500.00K
Shares Held After
187,171
% of Holdings
2.1%
AbCellera Biologics Inc. (ABCL)
Booth Andrew — Chief Financial Officer
Shares
42,600
Price
$3.42
Total Value
$145.69K
Shares Held After
195,600
% of Holdings
21.8%
MYRIAD GENETICS INC (MYGN)
Phanstiel S. Louise — Director
Shares
48,000
Price
$4.66
Total Value
$223.73K
Shares Held After
281,951
% of Holdings
17.0%
Edesa Biotech, Inc. (EDSA)
Brooks Michael J — President
Shares
2,000
Price
$1.57
Total Value
$3.14K
Shares Held After
226,870
% of Holdings
0.9%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
20,571
Price
$1.58
Total Value
$32.48K
Shares Held After
615,797
% of Holdings
3.3%
Bicara Therapeutics Inc. (BCAX)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
300,000
Price
$16.00
Total Value
$4.80M
Shares Held After
4,603,418
% of Holdings
6.5%
AdaptHealth Corp. (AHCO)
Rew Richard W. II — CLO and General Counsel
Shares
5,000
Price
$8.91
Total Value
$44.55K
Shares Held After
107,097
% of Holdings
4.7%
MYRIAD GENETICS INC (MYGN)
Phanstiel S. Louise — Director
Shares
50,407
Price
$4.80
Total Value
$242.10K
Shares Held After
233,951
% of Holdings
21.5%
AbCellera Biologics Inc. (ABCL)
Thermopylae Holdings Ltd. — 10% Owner
Shares
177,457
Price
$3.27
Total Value
$580.28K
Shares Held After
56,096,097
% of Holdings
0.3%
Sintx Technologies, Inc. (SINT)
Lyons Christopher Michael — Director
Shares
758
Price
$2.96
Total Value
$2.24K
Shares Held After
758
% of Holdings
100.0%
MYRIAD GENETICS INC (MYGN)
Phanstiel S. Louise — Director
Shares
6,100
Price
$4.74
Total Value
$28.89K
Shares Held After
183,544
% of Holdings
3.3%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
2,000
Price
$1.49
Total Value
$2.98K
Shares Held After
1,906,186
% of Holdings
0.1%
INSULET CORP (PODD)
MINOGUE MICHAEL R — Director
Shares
2,030
Price
$246.23
Total Value
$499.85K
Shares Held After
17,483
% of Holdings
11.6%
Cocrystal Pharma, Inc. (COCP)
FROST PHILLIP MD ET AL — Director
Shares
20,000
Price
$1.00
Total Value
$19.95K
Shares Held After
1,908,551
% of Holdings
1.0%
Candel Therapeutics, Inc. (CADL)
Manning Paul B — Director
Shares
550,458
Price
$5.45
Total Value
$3.00M
Shares Held After
2,763,527
% of Holdings
19.9%
HUMANA INC (HUM)
Shetty Sanjay K — President, CenterWell
Shares
810
Price
$185.21
Total Value
$150.02K
Shares Held After
11,657
% of Holdings
6.9%
Sintx Technologies, Inc. (SINT)
MOYES JAY M — Director
Shares
1,000
Price
$2.91
Total Value
$2.91K
Shares Held After
4,000
% of Holdings
25.0%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
100,000
Price
$1.47
Total Value
$147.00K
Shares Held After
1,904,186
% of Holdings
5.3%
Bausch & Lomb Corp (BLCO)
COLLIS STEVEN H — Director
Shares
15,000
Price
$17.81
Total Value
$267.15K
Shares Held After
20,255
% of Holdings
74.1%
CVRx, Inc. (CVRX)
Jain Mudit K. — Director
Shares
46,800
Price
$6.36
Total Value
$297.59K
Shares Held After
980,183
% of Holdings
4.8%
OCULAR THERAPEUTIX, INC (OCUL)
LINDSTROM RICHARD L MD — Director
Shares
60,229
Price
$7.66
Total Value
$461.35K
Shares Held After
246,933
% of Holdings
24.4%
Bausch & Lomb Corp (BLCO)
ROBERTSON RUSSEL C — Director
Shares
4,400
Price
$17.90
Total Value
$78.76K
Shares Held After
72,407
% of Holdings
6.1%
ARDELYX, INC. (ARDX)
MOTT DAVID M — Director
Shares
333,333
Price
$5.84
Total Value
$1.95M
Shares Held After
3,302,918
% of Holdings
10.1%
ACCURAY INC (ARAY)
MAYER STEVEN F — Director
Shares
54,875
Price
$0.56
Total Value
$30.88K
Shares Held After
1,545,620
% of Holdings
3.6%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
100,000
Price
$1.48
Total Value
$147.79K
Shares Held After
1,804,186
% of Holdings
5.5%
INSULET CORP (PODD)
McEvoy Ashley — Director
Shares
4,300
Price
$239.35
Total Value
$1.03M
Shares Held After
13,916
% of Holdings
30.9%
MapLight Therapeutics, Inc. (MPLT)
Pavlov George — Director
Shares
9,920
Price
$17.86
Total Value
$177.17K
Shares Held After
25,000
% of Holdings
39.7%
Avantor, Inc. (AVTR)
LUCIER GREGORY T — Director
Shares
50,000
Price
$9.16
Total Value
$458.00K
Shares Held After
50,000
% of Holdings
100.0%
Bausch & Lomb Corp (BLCO)
Ling Karen — Director
Shares
4,000
Price
$17.74
Total Value
$70.97K
Shares Held After
41,676
% of Holdings
9.6%
AVITA Medical, Inc. (RCEL)
O'Toole David D — CFO
Shares
3,000
Price
$4.15
Total Value
$12.45K
Shares Held After
140,127
% of Holdings
2.1%
Showing 1–50 of 171 transactions (page 1 of 4)